`CERTIFICATE OF CORRECTION
`
`: 6,926,907 B2
`PATENT NO.
`APPLICATIONNO. : 10/158216
`DATED
`:August 9, 2005
`: John P1achetka
`INVENTOR(S)
`
`Page 1 of 3
`
`It is certified that error appears in the above-identified patent and that said Letters Patent is
`hereby corrected as shown below:
`
`In the first line of claim 1 line 1 in the issued patent, the word "dose" should
`
`be --dosage.-- Thus, the correct claim should read as follows:
`
`Col. 20, Claim
`
`1.
`
`A pharmaceutical composition in unit dosage form suitable for oral
`
`administration to a patient, comprising: (a) an acid inhibitor present in an
`
`amount effective to raise the gastric pH of said patient to at least 3.5 upon the
`
`administration of one or more of said unit dosage forms; (b) a non-steroidal
`
`anti-inflammatory drug (NSAID) in an amount effective to reduce or eliminate
`
`pain or inflammation in said patient upon administration of one or more of said
`
`unit dosage forms;
`
`and wherein said unit dosage form provides for coordinated release such that:
`
`i) said NSAID is surrounded by a coating that, upon ingestion of said unit
`
`dosage form by said patient, prevents the release of essentially any NSAID from
`
`said dosage form unless the pH of the surrounding medium is 3.5 or higher; ii)
`
`at least a portion of said acid inhibitor is not surrounded by an enteric coating
`
`and, upon ingestion of said unit dosage form by said patient, is released
`
`regardless of whether the pH of the surrounding medium is below 3.5 or above
`
`3.5.
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`CERTIFICATE OF CORRECTION
`
`: 6,926,907 B2
`PATENT NO.
`APPLICATIONNO. : 10/158216
`DATED
`:August 9, 2005
`INVENTOR(S)
`: John P1achetka
`
`Page 2 of 3
`
`It is certified that error appears in the above-identified patent and that said Letters Patent is
`hereby corrected as shown below:
`
`Col. 21, Line 1 of claim 16 and 17 should refer to "any one of claims 12-14" and
`
`not to "claim 15." In addition, the phrase --wherein said acid inhibitor is a proton pump
`
`inhibitor-- should be included in 16 and 17. Thus, the claims should read as follows:
`
`Col. 21
`
`16. The pharmaceutical composition of any one of claims 12-14, wherein said acid
`
`inhibitor is a proton pump inhibitor and wherein said coating surrounding said
`
`core does not dissolve unless the pH of the surrounding medium is 4 or greater.
`
`17. The pharmaceutical composition of any one of claims 12-14, wherein said acid
`
`inhibitor is a proton pump inhibitor and wherein said coating surrounding said
`
`core does not dissolve unless the pH of the surrounding medium is 5 or greater.
`
`Col. 21, Line 1 of claims 19 and 20 should refer to "any one of claims 12-14" and
`
`not to "claim 18." In addition, the phrase --wherein said acid inhibitor is an H2
`
`blocker-- should be included in 19 and 20. Thus, the claims should read as
`follows:
`
`Col. 21
`
`19. The pharmaceutical composition of any one of claims 12-14, wherein said acid
`
`inhibitor is an H2 blocker and wherein said tablet has an inner core of said
`
`NSAID surrounded by a barrier coating that dissolves at a rate such that said
`
`NSAID is not released until the pH of the surrounding medium is 4 or greater.
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`CERTIFICATE OF CORRECTION
`
`: 6,926,907 B2
`PATENT NO.
`APPLICATIONNO. : 10/158216
`DATED
`:August 9, 2005
`INVENTOR(S)
`: John P1achetka
`
`Page 3 of 3
`
`It is certified that error appears in the above-identified patent and that said Letters Patent is
`hereby corrected as shown below:
`
`Col. 21
`
`20. The pharmaceutical composition of any one of claims 12-14, wherein said acid
`
`inhibitor is an H2 blocker and wherein said tablet has an inner core of said NSAID
`
`surrounded by a barrier coating that dissolves at a rate such that said NSAID is not
`
`released until the pH of the surrounding medium is 5 or greater.
`
`Signed and Sealed this
`
`Twenty-fifth Day of December, 2007
`
`JONW.DUDAS
`Director of the United States Patent and Trademark Office